2024 ESMO Annual Meeting Insights Hub
L

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvalumab in Unresectable HCC

By 2024 ESMO Annual Meeting Insights Hub FEATURING Lorenza Rimassa
By 2024 ESMO Annual Meeting Insights Hub FEATURING Lorenza Rimassa
93 views
September 20, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
10:57
UCLA Health

Y90 Radioembolization for Locally Advanced HCC

Feat. S. Padia
15:30
Yale Cancer Center

Updates in Combination Therapy for HCC

Feat. S. Stein
25:09
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC…

Feat. R. Kim, T. Biachi
26:59
University of Texas Southwestern Medical Center

2023 AASLD Guidance for HCC

Feat. A. Singal
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
13:58
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 &am…

Feat. R. Kim, T. Biachi
15:53
Yale Cancer Center

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Feat. A. Jaffe
27:48
Lionel Kankeu Fonkoua

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

22:02
ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

Feat. R. Wong
09:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary C…

Feat. N. Uboha, K. Spencer, M. Cecchini
14:14
Stanford Medicine

HCC: Updates in Management

Feat. R. Dhanasekaran
08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
20:09
2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

Feat. L. Rimassa
21:11
Stanford Medicine

Hepatocellular Carcinoma: Current Management Strategies

Feat. R. Dhanasekaran
09:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and …

Feat. A. Vogel
11:47
Johns Hopkins

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Feat. M. Baretti
15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott